Chong‐Ock Lee

920 total citations
33 papers, 819 citations indexed

About

Chong‐Ock Lee is a scholar working on Organic Chemistry, Molecular Biology and Toxicology. According to data from OpenAlex, Chong‐Ock Lee has authored 33 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Organic Chemistry, 18 papers in Molecular Biology and 16 papers in Toxicology. Recurrent topics in Chong‐Ock Lee's work include Bioactive Compounds and Antitumor Agents (16 papers), Synthesis and biological activity (15 papers) and Cancer therapeutics and mechanisms (10 papers). Chong‐Ock Lee is often cited by papers focused on Bioactive Compounds and Antitumor Agents (16 papers), Synthesis and biological activity (15 papers) and Cancer therapeutics and mechanisms (10 papers). Chong‐Ock Lee collaborates with scholars based in South Korea, India and Germany. Chong‐Ock Lee's co-authors include Myung‐Eun Suh, Sang‐Un Choi, Sang Kook Lee, Hyunjung Lee, Hea‐Young Park Choo, Hyen Joo Park, Jin Sung Kim, Young Choong Kim, Jee H. Jung and Sam Sik Kang and has published in prestigious journals such as Phytochemistry, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Chong‐Ock Lee

33 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chong‐Ock Lee South Korea 19 486 439 207 101 81 33 819
Byung-Zun Ahn South Korea 16 420 0.9× 391 0.9× 172 0.8× 101 1.0× 68 0.8× 26 719
Chung‐Kyu Ryu South Korea 23 900 1.9× 390 0.9× 410 2.0× 109 1.1× 33 0.4× 67 1.3k
Juan C. Estévez Spain 20 1.0k 2.1× 537 1.2× 153 0.7× 124 1.2× 52 0.6× 113 1.2k
Ewa Bębenek Poland 18 298 0.6× 634 1.4× 170 0.8× 66 0.7× 117 1.4× 68 903
Jack B. Jiang United States 11 497 1.0× 587 1.3× 48 0.2× 96 1.0× 98 1.2× 17 1.1k
Barbora Orlikova Luxembourg 18 304 0.6× 444 1.0× 76 0.4× 244 2.4× 99 1.2× 23 926
Gousia Chashoo India 19 407 0.8× 383 0.9× 46 0.2× 134 1.3× 98 1.2× 39 899
Ioannis K. Kostakis Greece 18 476 1.0× 280 0.6× 104 0.5× 131 1.3× 77 1.0× 56 776
Elwira Chrobak Poland 17 284 0.6× 491 1.1× 158 0.8× 56 0.6× 76 0.9× 67 742
Satyam Kumar Agrawal India 15 351 0.7× 300 0.7× 82 0.4× 54 0.5× 59 0.7× 43 736

Countries citing papers authored by Chong‐Ock Lee

Since Specialization
Citations

This map shows the geographic impact of Chong‐Ock Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong‐Ock Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong‐Ock Lee more than expected).

Fields of papers citing papers by Chong‐Ock Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chong‐Ock Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong‐Ock Lee. The network helps show where Chong‐Ock Lee may publish in the future.

Co-authorship network of co-authors of Chong‐Ock Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Chong‐Ock Lee. A scholar is included among the top collaborators of Chong‐Ock Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chong‐Ock Lee. Chong‐Ock Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Go, Ara, Seunghyun Jo, Ji Eun Kim, et al.. (2019). A novel cereblon modulator for targeted protein degradation. European Journal of Medicinal Chemistry. 166. 65–74. 43 indexed citations
2.
Elkamhawy, Ahmed, Ae Nim Pae, Jin-Chul Heo, et al.. (2015). Discovery of potent and selective cytotoxic activity of new quinazoline-ureas against TMZ-resistant glioblastoma multiforme (GBM). European Journal of Medicinal Chemistry. 103. 210–222. 21 indexed citations
3.
Park, Hyen Joo, et al.. (2006). Synthesis, cytotoxicity, and DNA topoisomerase II inhibitory activity of benzofuroquinolinediones. Bioorganic & Medicinal Chemistry. 15(4). 1651–1658. 40 indexed citations
4.
Kim, Geum‐Soog, Hyuntae Kim, Sei‐Ryang Oh, et al.. (2005). Cytotoxic Steroidal Saponins from the Rhizomes of Asparagus oligoclonos. Journal of Natural Products. 68(5). 766–768. 24 indexed citations
5.
Lee, Hyunjung, et al.. (2004). Synthesis and cytotoxicity evaluation of 6,11-dihydro-pyridazo- and 6,11-dihydro-pyrido[2,3-b]phenazine-6,11-diones. Bioorganic & Medicinal Chemistry. 12(7). 1623–1628. 41 indexed citations
6.
7.
Cheon, Seung Hoon, et al.. (2001). Structure-activity relationship studies of isoquinolinone type anticancer agent. Archives of Pharmacal Research. 24(4). 276–280. 10 indexed citations
8.
9.
Ryu, Chung‐Kyu, et al.. (2000). Cytotoxic activities of 6-arylamino-7-halo-5,8-quinolinediones against human tumor cell lines. Archives of Pharmacal Research. 23(1). 42–45. 8 indexed citations
10.
Ryu, Chung‐Kyu, et al.. (2000). Modulation of NAD(P)H:Quinone oxidoreductase (NQO1) activity mediated by 5-arylamino-2-methyl-4,7-dioxobenzothiazoles and their cytotoxic potential. Archives of Pharmacal Research. 23(6). 554–558. 10 indexed citations
11.
Jung, Sang‐Hun, et al.. (2000). Stereochemical requirement at 4-position of 4-phenyl-1-arylsulfonylimidazolidinones for their cytotoxicities. Archives of Pharmacal Research. 23(1). 35–41. 12 indexed citations
12.
Ahn, Jong‐Woong, Sunghee Woo, Chong‐Ock Lee, Kwang‐Yun Cho, & Byung–Sup Kim. (1999). KR025, a New Cytotoxic Compound from Myxococcus fulvus. Journal of Natural Products. 62(3). 495–496. 22 indexed citations
13.
Cho, Won‐Jea, et al.. (1998). Synthesis of antineoplaston A10 analogs as potential antitumor agents. Archives of Pharmacal Research. 21(2). 157–163. 3 indexed citations
14.
Choi, Sang‐Un, Sung-Hee Park, Kwang Hee Kim, et al.. (1998). The bis benzylisoquinoline alkaloids, tetrandine and fangchinoline, enhance the cytotoxicity of multidrug resistance-related drugs via modulation of P-glycoprotein. Anti-Cancer Drugs. 9(3). 255–262. 56 indexed citations
15.
Cheon, Seung Hoon, et al.. (1998). Synthesis and structure-activity relationship studies of substituted isoquinoline analogs as antitumor agent. Archives of Pharmacal Research. 21(2). 193–197. 7 indexed citations
16.
Cho, Won‐Jea, et al.. (1997). Synthesis and antitumor activity of 3-arylisoquinoline derivatives. Archives of Pharmacal Research. 20(3). 264–268. 12 indexed citations
17.
Cheon, Seung Hoon, et al.. (1997). Synthesis and structure-activity relationship studies of 2,3-dihydroimidazo[2,1-a]isoquinoline analogs as antitumor agents. Archives of Pharmacal Research. 20(2). 138–143. 6 indexed citations
18.
Choi, Sang‐Un, et al.. (1994). Synthesis of Mannich bases of Antineoplaston A10 and their antitumor activity. Archives of Pharmacal Research. 17(6). 467–469. 3 indexed citations
19.
Kim, Yoojin, et al.. (1984). Studies on Antitumor Components of Cultured Basidiomycetes - Purification and Chemical Analysis of Antineoplastic Constituents of Cultured Mycelia of Laccaria laccata -. The Korean Journal of Mycology. 12(1). 35–43. 1 indexed citations
20.
Kwon, Taejoon, et al.. (1980). Studies on the Constituents of Higher Fungi of Korea(XXI) - A Sterol from Calvatia saccatum (Vahl.) Fr. -. The Korean Journal of Mycology. 8(1). 25–28. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Byung-Zun Ahn Breakdown of academic impact, for papers by Chung‐Kyu Ryu Breakdown of academic impact, for papers by Juan C. Estévez Breakdown of academic impact, for papers by Ewa Bębenek Breakdown of academic impact, for papers by Jack B. Jiang Breakdown of academic impact, for papers by Barbora Orlikova Breakdown of academic impact, for papers by Gousia Chashoo Breakdown of academic impact, for papers by Ioannis K. Kostakis Breakdown of academic impact, for papers by Elwira Chrobak Breakdown of academic impact, for papers by Satyam Kumar Agrawal
Rankless by CCL
2026